HeartBeam's 1st synthesized 12-lead ECG cleared by FDA, enabling cable-free at-home arrhythmia assessment with launch set for 2026.

Austin, Texas, United States, December 10th, 2025, FinanceWire HeartBeam (NASDAQ: BEAT), a medical technology company focused ...

While electrocardiograms are often the first test ordered to diagnose heart disease, they’re not as accurate as many think. Ennovea Medical is cutting down on electrode placement errors with a ...

Guwahati: A research collaboration between NIPER Guwahati's medical devices department, IIT Guwahati and AIIMS Guwahati has produced an innovative ultra-thin tattoo electrode for skin application. The ...

Unlike any single-lead or 6-lead consumer device, HeartBeam's patented cable-free technology captures the heart's electrical signals in three non-coplanar dimensions and synthesizes them into a ...

Standard ADC components seldom provide enough flexibility to meet the conflicting needs of today’s medical designs. By Ian ...

Researchers have developed a non-invasive, reusable 'ECG vest' that takes high-resolution images of the heart's electrical activity in five minutes. Combining its data with cardiac MRI scans can ...

Secures FDA 510(K) Clearance For 12-Lead ECG Synthesis Software Following Successful Appeal. HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through ...